1. Home
  2. YSXT vs RVPH Comparison

YSXT vs RVPH Comparison

Compare YSXT & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSXT
  • RVPH
  • Stock Information
  • Founded
  • YSXT 2011
  • RVPH 2006
  • Country
  • YSXT China
  • RVPH United States
  • Employees
  • YSXT N/A
  • RVPH N/A
  • Industry
  • YSXT Automotive Aftermarket
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSXT Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • YSXT Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • YSXT 87.9M
  • RVPH 88.0M
  • IPO Year
  • YSXT 2024
  • RVPH N/A
  • Fundamental
  • Price
  • YSXT $2.60
  • RVPH $2.09
  • Analyst Decision
  • YSXT
  • RVPH Strong Buy
  • Analyst Count
  • YSXT 0
  • RVPH 5
  • Target Price
  • YSXT N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • YSXT 72.9K
  • RVPH 1.8M
  • Earning Date
  • YSXT 01-01-0001
  • RVPH 11-14-2024
  • Dividend Yield
  • YSXT N/A
  • RVPH N/A
  • EPS Growth
  • YSXT N/A
  • RVPH N/A
  • EPS
  • YSXT 0.21
  • RVPH N/A
  • Revenue
  • YSXT $58,546,729.00
  • RVPH N/A
  • Revenue This Year
  • YSXT N/A
  • RVPH N/A
  • Revenue Next Year
  • YSXT N/A
  • RVPH N/A
  • P/E Ratio
  • YSXT $11.80
  • RVPH N/A
  • Revenue Growth
  • YSXT 18.92
  • RVPH N/A
  • 52 Week Low
  • YSXT $2.06
  • RVPH $0.60
  • 52 Week High
  • YSXT $6.27
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • YSXT N/A
  • RVPH 60.41
  • Support Level
  • YSXT N/A
  • RVPH $1.78
  • Resistance Level
  • YSXT N/A
  • RVPH $2.15
  • Average True Range (ATR)
  • YSXT 0.00
  • RVPH 0.15
  • MACD
  • YSXT 0.00
  • RVPH 0.02
  • Stochastic Oscillator
  • YSXT 0.00
  • RVPH 88.30

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: